The noncoding human genome and the future of personalised medicine.
about
Genetic markers predicting sulphonylurea treatment outcomes in type 2 diabetes patients: current evidence and challenges for clinical implementation.p27Kip1, PCAF and PAX5 cooperate in the transcriptional regulation of specific target genes.Involvement of Non-coding RNAs in the Signaling Pathways of Colorectal Cancer.ChIP-Seq analysis identifies p27(Kip1)-target genes involved in cell adhesion and cell signalling in mouse embryonic fibroblasts.Validation of genotype imputation in Southeast Asian populations and the effect of single nucleotide polymorphism annotation on imputation outcome.Towards a map of cis-regulatory sequences in the human genome.
P2860
The noncoding human genome and the future of personalised medicine.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
The noncoding human genome and the future of personalised medicine.
@en
type
label
The noncoding human genome and the future of personalised medicine.
@en
prefLabel
The noncoding human genome and the future of personalised medicine.
@en
P2093
P2860
P356
P1476
The noncoding human genome and the future of personalised medicine.
@en
P2093
Alasdair MacKenzie
Elizabeth A Hay
Philip Cowie
P2860
P356
10.1017/ERM.2014.23
P577
2015-01-30T00:00:00Z